NKG2D-deprived knockout mice demonstrate a stronger incidence or burden of cancer in multiple cancer models, and the role of NKG2D in cancer immunosurveillance, including genetically engineered models of spontaneous cancer [216]. This evidence concerns the gene KLRK1 and cancer.